These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15922928)

  • 21. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment adherence with antipsychotic medications in bipolar disorder.
    Sajatovic M; Valenstein M; Blow FC; Ganoczy D; Ignacio RV
    Bipolar Disord; 2006 Jun; 8(3):232-41. PubMed ID: 16696824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder.
    Urbano MR; Ware JC
    J Clin Psychopharmacol; 2008 Dec; 28(6):704-5. PubMed ID: 19011442
    [No Abstract]   [Full Text] [Related]  

  • 26. Quetiapine-induced rabbit syndrome in a patient with bipolar disorder.
    Wu CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):2002-3. PubMed ID: 18809453
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bipolar disorder and somatic comorbidity].
    Corruble E
    Encephale; 2008 Jun; 34 Suppl 4():S143-5. PubMed ID: 18707937
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of rapid cycling bipolar disorders.
    Hotujac L
    Neuro Endocrinol Lett; 2005 Aug; 26 Suppl 1():67-73. PubMed ID: 16361989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing side effects of pharmacotherapy treatment of bipolar disorder: a 20-year review of the literature.
    Matson JL; González ML; Smith KR; Terlonge C; Thorson RT; Dixon DR
    Res Dev Disabil; 2006; 27(5):467-500. PubMed ID: 16143494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME
    J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot antipsychotic medications in bipolar disorder: a review of the literature.
    Bond DJ; Pratoomsri W; Yatham LN
    Acta Psychiatr Scand Suppl; 2007; (434):3-16. PubMed ID: 17688458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptides and retinal development.
    Casini G
    Arch Ital Biol; 2005 Sep; 143(3-4):191-8. PubMed ID: 16097495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Pharmacopsychiatry; 2008 Nov; 41(6):240-1. PubMed ID: 19067261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional gray matter changes in bipolar disorder: a voxel-based morphometric study.
    Chen X; Wen W; Malhi GS; Ivanovski B; Sachdev PS
    Aust N Z J Psychiatry; 2007 Apr; 41(4):327-36. PubMed ID: 17464719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of bipolar disorder during pregnancy.
    Cohen LS
    J Clin Psychiatry; 2007; 68 Suppl 9():4-9. PubMed ID: 17764378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.